{"title":"Criteria for the Use of Tramadol in Adult Patients: Medication-Use Evaluation Guidelines","authors":"J. Generali","doi":"10.18553/JMCP.1999.5.6.492","DOIUrl":null,"url":null,"abstract":"OBJECTIVE: To develop a practical medication-use evaluation (MUE) tool flexible enough to be used in a variety of practice settings. SETTING: Institutional health care systems or managed care organizations, although the format may be adapted for use by consultant pharmacists. DESIGN: This MUE has been designed for use as part of a comprehensive outcome monitoring program. It focuses on a particular agent (tramadol hydrochloride) that has significant cost and usage implications. MAIN OUTCOME MEASURES: Appropriate patient populations and desired therapeutic outcomes can be identified with the use of this MUE. Customized interventions that are appropriate to each organization may. RESULTS: This MUE can provide a framework for institutional health care systems and' MCOs to use in developing a comprehensive monitoring program for tramadol hydrochloride and an oral analgesic. CONCLUSION: Effective high-quality pharmaceutical care incorporates the use of assessment methods that monitor patient outcomes and medic...","PeriodicalId":50156,"journal":{"name":"Journal of Managed Care Pharmacy","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2015-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Managed Care Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18553/JMCP.1999.5.6.492","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7
Abstract
OBJECTIVE: To develop a practical medication-use evaluation (MUE) tool flexible enough to be used in a variety of practice settings. SETTING: Institutional health care systems or managed care organizations, although the format may be adapted for use by consultant pharmacists. DESIGN: This MUE has been designed for use as part of a comprehensive outcome monitoring program. It focuses on a particular agent (tramadol hydrochloride) that has significant cost and usage implications. MAIN OUTCOME MEASURES: Appropriate patient populations and desired therapeutic outcomes can be identified with the use of this MUE. Customized interventions that are appropriate to each organization may. RESULTS: This MUE can provide a framework for institutional health care systems and' MCOs to use in developing a comprehensive monitoring program for tramadol hydrochloride and an oral analgesic. CONCLUSION: Effective high-quality pharmaceutical care incorporates the use of assessment methods that monitor patient outcomes and medic...